No-PAINNCT05842044
NSAID Use After Robotic Partial Nephrectomy
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 8 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Enrollment closed, study ongoing
- Final enrollment: 137 participants (planned 110)
- Primary completion date changed from estimate of Sep 30, 2026 to Oct 9, 2026
- Site details revised
- Notable Eligibility criteria expanded, about 12 words
- Study completion pushed from Sep 30, 2026 to Dec 31, 2026
- Secondary endpoints: details revised at 2 of 5 entries
- Notable Primary and study completion dates: Sep 30, 2025 to Sep 30, 2026v7
- Minor Primary and study completion dates: Sep 5, 2025 to Sep 30, 2025
- Start date: Sep 5, 2023 to Sep 15, 2023
- Secondary endpoints: details revised at 4 of 5 entries
- Notable Trial status: Not Yet Recruiting to Recruiting
- Site details revised
Show 2 earlier versionsHide 2 earlier versions
- Minor Primary and study completion dates: Aug 31, 2025 to Sep 5, 2025
- Start date: Aug 31, 2023 to Sep 5, 2023
- Notable Start date: Jul 31, 2023 to Aug 31, 2023
- Primary and study completion dates: Jul 31, 2025 to Aug 31, 2025
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Rate of Opioid Use in Postoperative Period
Timeframe: Up to 20 days
Secondary (5)
Rate of Opioid Medication Use during Hospitalization
Pain Score Assessed by Standardized Script
Pain Score Assessed by International Pain Outcome Questionnaire
Number of Treatment-Related Adverse Events
Change in Rate of Acute Kidney Injury
Arms and interventions
Group 1: NSAIDExperimental
Participants in this group will be prescribed NSAIDs instead of the standard of care treatment. Participants will be in this group for approximately 21 days.
Group 2: No-NSAIDActive comparator
Participants in this group will follow standard of care treatment. Participants will be in this group for approximately 21 days.
Drugs: Ketorolac, Acetaminophen, Oxycodone, Hydromorphone, Ibuprofen
Sites
1 site in 1 country
- University of MiamiMiami, Florida, United States